FEASIBILITY AND EFFICACY OF DHAOX REGIMEN AS SALVAGE AND MOBILIZING THERAPY IN RELAPSED /REFRACTORY LYMPHOMAS

被引：0
|
作者：
Coviello, E. [1 ]
Giannoni, L. [1 ]
Pastori, G. [1 ]
Mitscheunig, L. [1 ]
Avenoso, D. [1 ]
Minetto, P. [1 ]
Guolo, F. [1 ]
Miglino, M. [1 ]
Clavio, M. [1 ]
Lemoli, R. M. [1 ]
Marco, G. [1 ]
Ballerini, F. [1 ]
机构：
[1] Univ Genoa, IRCCS AOU San Martino IST, Dept Internal Med DiMI, Chair Hematol, Genoa, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E972
引用
收藏
页码：399 / 400
页数：2
相关论文
共 50 条
  • [31] Salvage therapy for refractory or relapsed acute lymphocytic leukemia
    Garcia-Manero, G
    Thomas, DA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (01) : 163 - +
  • [32] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [33] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, Maximilian J.
    Truger, Marietta
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Haferlach, Claudia
    Mersi, Julia
    Waldschmidt, Johannes
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
  • [34] Salvage therapy for relapsed or refractory acute myeloid leukemia
    Mangan, James K.
    Luger, Selina M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 73 - 82
  • [35] Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas
    López, R
    Martino, R
    Brunet, S
    Sureda, A
    Domingo-Albós, A
    Sierra, J
    HAEMATOLOGICA, 1999, 84 (10) : 911 - 916
  • [36] Safety and cost effectiveness of outpatient administration of salvage chemotherapy for relapsed/refractory lymphomas
    Maghfoor, I.
    Youssef, I.
    Rauf, M. S.
    Akhtar, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S554 - S554
  • [37] Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas
    Hou Yun
    Hui lai Zhang
    Hua-qing Wang
    Medical Oncology, 2015, 32
  • [38] Rituximab and bortezomib (RB): a new effective regimen for refractory or relapsed indolent lymphomas
    Yun, Hou
    Zhang, Hui Lai
    Wang, Hua-qing
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 8
  • [39] MODIFIED VIGEPP PROTOCOLE AS A NEW SALVAGE REGIMEN FOR RELAPSED REFRACTORY LYMPHOMA PATIENTS
    Kayikci, O.
    Tekgunduz, E.
    Bozdag, S.
    Demiriz, I.
    Tetik, A.
    Cinarsoy, M.
    Namdaroglu, S.
    Ugur, B.
    Altuntas, F.
    HAEMATOLOGICA, 2013, 98 : 645 - 646
  • [40] FLAG-IDA REGIMEN AS SALVAGE THERAPY IN REFRACTORY/RELAPSED AML PATIENTS: A SINGLE-CENTER EXPERIENCE
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Pasciolla, C.
    Bitetti, C.
    Franco, A.
    Anelli, L.
    Mestice, A.
    Albano, F.
    Specchia, G.
    HAEMATOLOGICA, 2016, 101 : 383 - 383
12345